PLATELET-DERIVED GROWTH FACTORS AS POSSIBLE MEDIATORS OF VASCULAR PROLIFERATION IN THE SPORADIC HAEMOLYTIC URAEMIC SYNDROME
- 1 October 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8511) , 830-833
- https://doi.org/10.1016/s0140-6736(86)92868-0
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The biology of platelet-derived growth factorCell, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Stimulation of aortic smooth muscle cell mitogenesis by serotonin.Proceedings of the National Academy of Sciences, 1986
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.Journal of Clinical Investigation, 1983
- Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion"Blood, 1982
- Hemolytic-Uremic Syndrome: Current Concepts and ManagementPediatric Clinics of North America, 1982
- The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.Journal of Clinical Investigation, 1977
- Hyperlipidemia and AtherosclerosisScience, 1976
- Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancyThe Journal of Pediatrics, 1973